Gait asymmetry and asymmetry index in a sample of patients with PD and control group in Cali – Colombia.
Objective: To objectively evaluate gait asymmetry and asymmetry index as a measure of gait in a sample of patients with PD compared to a control…A single aerobic exercise session of treadmill increases BDNF levels in Parkinson’s disease patients
Objective: The aim of this study was to investigate the effect of a single session moderate-intensity treadmill exercise on serum levels brain-derived neurotrophic factor (BDNF)…Wearing Off Frequency in Different Hoehn-Yahr Stages in Parkinson’s Disease
Objective: To determine wearing off frequency in different stages of Parkinson’s disease (PD). Background: Levodopa is the gold standard in the symptomatic treatment of PD. The…Efficacy of rotigotine as measured by individual Unified Parkinson’s Disease Rating Scale II and III items: a post-hoc analysis
Objective: The key aim was to assess the efficacy of rotigotine (RTG) transdermal patch on individual items of Unified Parkinson’s Disease Rating Scale (UPDRS) II…Aerobic Exercise Combined with rTMS for Parkinson’s Disease: A Randomized Trial
Objective: To explore clinical and neuro-physiological outcomes of aerobic exercise combined with real Vs sham repetitive transcranial magnetic stimulation (rTMS) over motor cortex (M1) in…Sample size estimation for clinical trials in de novo Parkinson’s disease (PD): Results from the Parkinson’s Progression Markers Initiative (PPMI) Study
Objective: To use clinical and biological data from PPMI to estimate sample size for disease modification studies in de novo PD Background: One barrier to…Moxibustion for Parkinson’s disease: a systematic review of randomized controlled trials
Objective: This systematic review aimed to evaluate effectiveness and safety of moxibustion therapy for IPD patients. Background: Idiopathic Parkinson’s disease (IPD) is a chronic neurodegenerative…How to switch from Entacapone to Opicapone based on BIPARK-I study experience
Objective: To clarify how easily can entacapone (ENT) be switched to opicapone (OPC), in levodopa-treated patients with Parkinson’s disease (PD) and motor-fluctuations. Background: OPC, a…Medical Treatment Termination in Parkinson’s Disease Patients after Hepad Therapy: A Case Series
Objective: To report seven clinical cases of treatment completion and improvement of symptoms after a PD therapy regimen that included Hepad. Background: DOPA decarboxylase inhibitor…Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease
Objective: (i)To elucidate the metabolic correlates sub-serving the clinical expression of ICD in PD and (ii) to evaluate the association between the glucose metabolism and…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 155
- Next Page »